CLINICAL TRIAL OF A NEW ORAL CONTRACEPTIVE PILL CONTAINING THE NATURAL OESTROGEN 17β‐OESTRADIOL
Authors:
- 1 September 1979
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 86 (9) , 732-736
Abstract
Summary: The natural oestrogen, 17β‐oestradiol, has been shown not to depress fibrinolysis and apparently has less influence on liver function and lipid metabolism than ethinyl oestradiol, the synthetic oestrogen in conventional‘combined’oral contraceptive tablets. A triple‐blind study was therefore made of 215 women during 2051 treatment cycles with oral contraceptives containing either (i) 4 mg of micronized 17‐oestradiol and 3 mg norethisterone (Netagen 403), (ii) 4 mg 17‐oestradiol plus 2 mg of oestriol and 3 mg norethisterone (Netagen 423) or (iii) 50 μg ethinyl oestradiol and 3 mg norethisterone (Netasyn). There were no pregnancies or thrombotic incidents. The numbers discontinuing treatment were about the same in the three groups, the main reasons being intermenstrual spotting in those on Netagen 423, amenorrhoea and weight gain in those on Netagen 403 and nausea and weight gain in those on Netasyn. The natural oestrogen showed promise as a new and safe component of the‘combined’pill.Keywords
This publication has 22 references indexed in Scilit:
- EFFECT OF GRADED ORAL DOSES OF OESTRADIOL ON CIRCULATING HORMONAL LEVELSEuropean Journal of Endocrinology, 1978
- Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.BMJ, 1978
- The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives.BMJ, 1977
- New aspects of the thrombogenic effect of oral contraceptivesAmerican Heart Journal, 1975
- 17‐β‐OESTRADIOL AND THE FIBRINOLYTIC ACTIVITY OF VEIN WALLSBJOG: An International Journal of Obstetrics & Gynaecology, 1974
- Thrombosis and Oral Contraceptives: Possible PredispositionBMJ, 1973
- Low Fibrinolytic Activity of Veins During Treatment with Ethinylo EstradiolActa Obstetricia et Gynecologica Scandinavica, 1971
- METABOLISM OF PROGESTAGENSThe Lancet, 1970
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- Venous effects of oral contraceptivesBMJ, 1969